Skip to main content
Sign In

Mark J. Abzug, MD

Professor of Pediatrics


Medical Director, Clinical Trials Organization

   Phone: 720-777-1234 (TBD)
   E-mail: (TBD)

Section of Infectious Diseases, Department of Pediatrics
Clinical Trials Organization
Children's Hospital Colorado

Pediatrics, Pediatric Infectious Diseases

Mark J. Abzug, MD, earned his medical degree from Boston University School of Medicine in 1982. In 1985 he completed pediatric residency training at the University of Rochester, including a Chief Residency in the Pediatric Ambulatory Department of Strong Memorial Hospital, Rochester, New York. Following pediatric infectious diseases fellowship training at the University of Colorado School of Medicine, Dr. Abzug joined the faculty of Children's Hospital Colorado and the Department of Pediatrics Section of Infectious Diseases in 1988. He is the Medical Director of the Clinical Trials Organization at Children's Hospital Colorado, which he co-founded in 1997. He served as interim Section Head of Pediatric Infectious Diseases from 2001-2002.

Dr. Abzug directs clinical research on patients with viral infections, infections in immune-compromised patients, and chronic sinusitis. He is involved in several national collaborative clinical trials of antiviral therapies, including the Enterovirus Subcommittee of the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group, which he has chaired since 2000, and the National Institutes of Health Pediatric AIDS Clinical Trials Group Opportunistic Infections and Metabolic Subcommittee, which he has chaired since 2003.

Dr. Abzug has been listed in Best Doctors in America, since 2005.

  • Co-Chair, Guidelines for Treatment and Prevention of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children Working Group, NIH-CDC-IDSA/HIVMA-PIDS-AAP, 2010-present
  • Co-Editor, Current Diagnosis and Treatment, 21st edition, 2010-present
  • Vice Chairman, Long-Term Follow-Up Subcommittee, International Maternal Pediatric Adolescent AIDS Clinical Trials Group, NIH, 2006-present
  • Member, Complications Scientific Committee, International Maternal Pediatric Adolescent AIDS Clinical Trials Group, NIH, 2006-present
  • Guide to America’s Top Physicians, 2009-present
  • Member, Subboard of Pediatric Infectious Diseases, ABP, 2005-2011
  • Reviewer, 2012 American Academy of Pediatrics Red Book, 2010
  • Associate Editor, Journal of Clinical Virology, 2005-2010
  • Invited International Guest Speaker, Federation of Infectious Diseases Societies of Southern Africa Biennial Meeting, Sun City, South Africa, 2009
  • Reviewer, Bill and Melinda Gates Foundation, 2009
  • Reviewer, Special Emphasis Panel, CDC, 2009
  • America’s Top Physicians, 2007
  • Invited Contributor, 2009 Red Book: Report of the Committee on Infectious Diseases, AAP, 2007
  • 5280 Magazine’s Top Doctors in Denver, 2005-2007
  • America’s Top Pediatricians, 2006
  • Chair, Enterovirus Subcommittee, Collaborative Antiviral Study Group, NIAID, NIH, 2000-2006
  • The Children's Hospital Outstanding Service Award, 2002


Publications in PubMed

  • Abzug MJ. The enteroviruses: an emerging infectious disease? The real, the speculative and the really speculative. Adv Exp Med Biol. 2008;609:1-15. [PMID: 18193653]
  • Abzug MJ. Viral meningitis and encephalitis. In: Rakel RE, Bope ET, editors. Conn's current therapy – 2008. Philadelphia: Saunders/Elsevier; 2008.
  • Abzug MJ, Song LY, Fenton T, Nachman SA, Levin MJ, Rosenblatt HM, Pelton SI, Borkowsky W, Edwards KM, Peters J. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. Pediatrics. 2007 Nov;120(5):e1190-202. [PMID: 17938165]
  • Brogly SB, Ylitalo N, Mofenson LM, Oleske J, Van Dyke R, Crain MJ, Abzug MJ, Brady M, Jean-Philippe P, Hughes MD, Seage GR 3rd. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children. AIDS. 2007 May;21(8):929-38. [PMID: 17457086]
  • Abzug MJ. Enteroviruses (non-poliovirus). In: Kliegman RM, Behrman R, Jenson HB, Stanton BF, editors. Nelson textbook of pediatrics. 18th ed. Philadelphia: Elsevier/Saunders; 2007.
  • Abzug MJ. Viral meningitis and encephalitis. In: Rakel RE, Bope ET, editors. Conn's current therapy – 2007. Philadelphia: Elsevier/Saunders; 2007.
  • Abzug MJ, Pelton SI, Song LY, Fenton T, Levin MJ, Nachman SA, Borkowsky W, Rosenblatt HM, Marcinak JF, Dieudonne A, Abrams EJ, Pathak I. Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2006 Oct;25(10):920-9. [PMID: 17006288]
  • Abzug MJ. Enteroviruses. In: Hutto C, editor. Congenital and perinatal infections: a concise guide to diagnosis. Totowa: Humana Press; 2006.
  • Abzug MJ. Viral meningitis and encephalitis. In: Burg FD, Ingelfinger JR, Polin RA, Gershon AA, editors. Current pediatric therapy. 18th ed. Philadelphia: Elsevier; 2006.
  • Greenberg RN, Mullane K, van Burik J-AH, Raad I, Abzug MJ, Anstead G, Herbrecht R, Langston A, Marr KA, Schiller G, Schuster M, Wingard JR, Gonzalez CE, Revankar SG, Corcoran G, Kryscio RJ, Hare R. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006;50(1):126-33. [PMID: 16377677]
  • Simmons JH, Zeitler PS, Fenton LZ, Abzug MJ, Fiallo-Scharer RV, Klingensmith GJ. Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the literature. Pediatr Diabetes. 2005 Dec;6(4):234-8. [PMID: 16390393]